CN105758984A - Method using derivatization HPLC-DAD method to determine small-molecule halogenated carboxylic acid in medicine - Google Patents

Method using derivatization HPLC-DAD method to determine small-molecule halogenated carboxylic acid in medicine Download PDF

Info

Publication number
CN105758984A
CN105758984A CN201510933250.5A CN201510933250A CN105758984A CN 105758984 A CN105758984 A CN 105758984A CN 201510933250 A CN201510933250 A CN 201510933250A CN 105758984 A CN105758984 A CN 105758984A
Authority
CN
China
Prior art keywords
carboxylic acid
derivatization
acid
halogenated carboxylic
hplc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510933250.5A
Other languages
Chinese (zh)
Other versions
CN105758984B (en
Inventor
郑枫
柳文媛
侯德胜
冯锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Pharmaceutical University
Original Assignee
China Pharmaceutical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Pharmaceutical University filed Critical China Pharmaceutical University
Priority to CN201510933250.5A priority Critical patent/CN105758984B/en
Publication of CN105758984A publication Critical patent/CN105758984A/en
Application granted granted Critical
Publication of CN105758984B publication Critical patent/CN105758984B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/89Inverse chromatography

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a method using a derivatization HPLC-DAD method to determine small-molecule halogenated carboxylic acid in medicine.The method includes: under normal temperature, using nitrobenzene hydrazine derivatization reagent to derivatize the small-molecule halogenated carboxylic acid so as to generate products with high absorption in the ultraviolet visible region; using the reaction liquid after the derivatization reaction as the feeding sample, and using the HPLC-DAD method to determine the derivatization products of halogenated carboxylic acid in the feeding sample in the ultraviolet visible region on the basis of the reversed phase partition chromatography principle so as to achieve the qualitative or quantitative detection of the small-molecule halogenated carboxylic acid.Due to the fact that the ultraviolet absorption band of the carboxylic acid derivatization products of the nitrobenzene hydrazine derivatization reagent has evident redshift effect due to the existence of nitro electron-withdrawing group on benzene ring and most medicine and impurities thereof are weak in absorption in the ultraviolet visible region (300-450 nanometers), the simple and universal method using pre-column derivatization HPLC-DAD to determine the small-molecule halogenated carboxylic acid is built.Methodology validation shows that the method is good in specificity.

Description

Derivatization HPLC-DAD method measures the method for medicine small molecular halogenated carboxylic acid
Technical field
The invention belongs to drugs analysis detection field, relate to derivatization HPLC-DAD method and measure the side of little molecule halogenated carboxylic acid Method, particularly relates to the method that derivatization HPLC-DAD method measures medicine small molecular halogenated carboxylic acid.
Background technology
Little molecule halogenated carboxylic acid (Halogenated carboxylic acids, HCAs), as main in water environment Disinfection byproduct (DBP), owing to having potential genotoxicity and carcinogenecity[1,2], receive many environment supervision departments very early and include Environmental Protection Agency USA (USEPA)[3], World Health Organization (WHO) (WHO)[4]Deng common concern, and be listed in the normal of water quality research One of rule monitoring index.In medical industry, this compounds is because having higher reactivity and special physiologically active (being introduced by halogen element)[5], it is often used as acylating agent active in organic synthesis or alkylating agent, in pesticide, medicine and other fields Extensive application[6-13], such as, monoxone can be used for synthetic vitamin B6, tadanafil, the intermediate of epinephrine etc.;2- Chloropropionic acid is commonly used for the initiation material of ibuprofen green production process;Bromoacetic acid and bromo-propionic acid class are usually used in herbicide, insecticide Preparation in pesticide.In addition to commercial production, affected by external condition during medicine storage and also can be produced halogenated carboxylic acid, such as Chloromycetin degraded generates dichloroacetic acid[14].Therefore this compounds tends to remain in medicine, and Excess free enthalpy may be right Human body works the mischief.The most commonly used toxicology pays close attention to threshold value (threshold of toxicological at present Concern, TTC) genotoxicity impurity is carried out limit handling[15-17].The limit of genotoxicity impurity is the most relatively low, therefore Need to set up high-sensitive analysis method this compounds in medicine is monitored.
Now, the method for most of documents report is both in the halogen acetic acid (Haloacetic measured in water environment acids,HAAs).Gas chromatogram serial electronic acquisition detector (GC-ECD) is classified as detection water ring by EPA (USEPA) The standard method of halogen acetic acid in border[18-21], the method needs to derive determinand the esters of chemical conversion volatile, then liquid liquid extraction Take enrichment, can be analyzed.The chromatography of ions (IC)[22,23]With reversed phase high-performance liquid chromatography (RP-LC)[24,25]Etc. liquid phase Chromatographic process, combined with electrochemical detector (ECD) or UV-detector (UV, 210nm) have been reported for the halogen in analysis water-like Acetic acid.These methods concentrate before generally requiring loaded down with trivial details post and clean operation could obtain enough specificities and sensitivity.Matter Spectrometry (MS), including hydrophilic Interaction Chromatography tandem mass spectrum (HILIC-MS)[26]、GC-MS[27,28]、LC-MS[29,30]And IC-MS[31 ,32]Content etc. the halogen acetic acid being also widely used in mensuration drinking water.Although mass detector is a kind of sensitive and general Detector, but fancy price limits promoting the use of of it.
Compared to water sample analysis, measure the little molecule halogenated carboxylic acid of residual in medicine and be faced with more challenge[14,16,33]。 First the complexity of medicine substrate is far above water sample, especially contain a large amount of the most similar to little molecule halogenated carboxylic acid character organic little Molecule, therefore it is required that analysis method possesses the specificity of height[16,33], so could effectively reduce interference;Another problem is Medicine itself is easily subject to extraneous factor impact degraded in operation and generates new little molecule halogenated carboxylic acid[14]Impact measures Result, the accuracy to result the simplest for this Pretreatment, gentle is the most favourable.In view of the above-mentioned fact, it is intended that These problems are improved by liquid phase Derivative.Liquid phase Derivative introduces specific by chemical reaction to determinand Group, is possible not only to improve detection sensitivity, moreover it is possible to improve the separating effect of determinand, be particularly suitable for little molecular polarity material Qualitative and quantitative analysis[34].Simone Jr etc.[35]After using post, the halogen acetic acid in drinking water is measured by fluorescence derivation, It is its derivatization reagent with nicotiamide, by laboratory homemade self-reacting device device to realize derivatization.But it is specific Device not only increases experimental cost, and is difficult to promote for conventional medicine analysis.Ghassempour et al.[36]Establish Glycine betaine sample monoxone and dichloroacetic acid are measured by pre-column derivatization-HPLC method.The method uses naphthalidine as spreading out Biochemical reagents, react 30min, detect subsequently under 220nm wavelength at 90 DEG C.The major defect of this method is: on the one hand, and high temperature holds It is easily generated degradation impurity[37];On the other hand, baseline noise is detected under low wavelength big, serious interference[38]
Nitrophenyl hydrazine (Nitro-substituted phenylhydrazines, NPHs) is classical carboxylic acids derivatization Reagent[38-45].Compared to phenyl amines, the carboxylic acid derivatization product of this kind of reagent is due to the depositing of nitro electron withdraw group on phenyl ring , there is obvious redshift effect in ultraviolet absorption band[39-41].Most drug and impurity thereof are purple near visible district (400nm) Outer absorption is the most weak, so being measured being greatly improved the specificity of method, summarized chromatogram separation condition at this wavelength.2- Nitrophenyl hydrazine (2-NPH)[38-43], 3-nitrophenyl hydrazine (3-NPH)[44], 4-nitrophenyl hydrazine (4-NPH)[45]And 2,4 dinitrophenyl hydrazine (2,4-DNPH)[43]It is the conventional commercialization Nitrobenzol hydrazine derivatization reagent of report at present, but about this kind of reagent Systematic comparison does not also have been reported that.Noonan etc.[38]People once with 2-nitrophenyl hydrazine as derivatization reagent, pyridine and 1-ethyl- Under the catalytic activation of (3-dimethylaminopropyl) carbodiimide hydrochloride, successfully the Fluoroethanoic acid in food is derived Change.This article mainly stresses the application at LC-MS, does not has the ultraviolet absorption characteristic to its product to carry out deep excavation.Therefore, Those skilled in the art cannot be speculated whether to use HPLC-DAD to derive Fluoroethanoic acid by information disclosed in the prior art Compound qualitatively or quantitatively detects.
Research shows that carboxylic acid and amido reaction need through 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride The activation of (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride, EDC HCl) Can carry out, and activation process is frequently added pyridine as catalyst[41].Therefore, inventor initially selects EDC HCl and pyrrole Pyridine accelerates hydrazides synthesis as catalyst system and catalyzing, and is successfully realized chloroacetic derivatization;But, when this condition is extended During to other detection objects, derivatization product occurs in that abnormal instability.We have found that conventional catalyst pyridine is easily made Become the dehalogenation phenomenon of alpha-halogen derivant.By adjusting reaction temperature, system pH and changing the type of nitrophenyl hydrazine the most not Can effectively solve the problems referred to above, this hampers the popularization and application of the method significantly.Also can through observing during discovery derived There is chlorination, and present in chlorination and system, hydrochlorates are relevant in a large number, and hydrochlorate is mainly derived from system EDC HCl and 2-NPH HCl.Although the probability that chlorination occurs can be reduced by reducing the consumption of hydrochlorate, But but can not check dechlorination reaction to occur.Reagent plus current commercialization all contains hydrochlorate, without hydrochlorate EDC and 2-NPH dissolubility is poor, considers, and the concentration only by reduction activator and derivatization reagent is effectively to change Kind derivant stability.
Summary of the invention
It is an object of the invention to the above-mentioned deficiency for prior art, it is provided that derivatization HPLC-DAD method measures little molecule halogen Method for carboxylic acid.
It is a further object of the present invention to provide the method that derivatization HPLC-DAD method measures medicine small molecular halogenated carboxylic acid.
The purpose of the present invention can be achieved through the following technical solutions:
Derivatization HPLC-DAD method measures the method for little molecule halogenated carboxylic acid, comprises the steps of
(1) at normal temperatures, Nitrobenzol hydrazine derivatization reagent is used to generate little molecule halogenated carboxylic acid derivatization in ultraviolet There is the product of stronger absorption visible region (320-450nm);
(2) reactant liquor after terminating using derivative reaction in step (1), as sample introduction sample, utilizes HPLC anti-phase distribution color Spectrometry measures the derivatization product of wherein halogenated carboxylic acid at ultraviolet-visible district (320-450nm), thus realizes little molecule halogen Qualitative or quantitative detection for carboxylic acid.
Described derivatization HPLC-DAD method measures the method for little molecule halogenated carboxylic acid, preferably comprises following steps:
(1) at normal temperatures, with acetonitrile-water as reaction system, with the hydrochlorate of carbodiimide class coupling agent as activator, make With Nitrobenzol hydrazine derivatization reagent, the generation of little molecule halogenated carboxylic acid derivative reaction there is stronger absorption 330~420nm Product;
(2) with derivative reaction product in step (1), utilize HPLC-DAD method, exist based on reversed phase partition chromatography principle 330~the 420nm derivatization products measuring wherein halogenated carboxylic acid, thus realize the qualitative or quantitative inspection to little molecule halogenated carboxylic acid Survey.
Wherein, described little molecule halogenated carboxylic acid preferably is selected from the carboxylic acid of C1~C6 of halogen substiuted, further preferred halogen The carboxylic acid of substituted C1~C4, further preferably monoxone, bromoacetic acid, dichloroacetic acid, 2-chloropropionic acid, 3-chloropropionic acid or 2-bromine Any one in propanoic acid.
Described carbon carbodiimide class coupling agent preferably is selected from dicyclohexylcarbodiimide, N, N'-DIC, Any one in 1-ethyl-(3-dimethylaminopropyl) carbodiimide;Further preferably 1-ethyl-(3-dimethylamino Propyl group) carbodiimide.
Nitrobenzol hydrazine derivatization reagent preferably is selected from 2-nitrophenyl hydrazine hydrochloride, 3-nitrophenyl hydrazine hydrochloride, 4-Nitrobenzol Any one in hydrazine hydrochloride and 2,4 dinitrophenyl hydrazine, further preferred 2-nitrophenyl hydrazine hydrochloride.
The condition of derivative reaction further preferably with acetonitrile-water=10:90~90:10 (V:V) as reaction system, 2-nitre Base phenyl hydrazine hydrochloride salinity is 0.2~3mg/mL, and EDC HCl concentration is 1~4mg/mL, reacts 1~3h;The most preferred Under room temperature, with acetonitrile-water=70:30 (V:V) as reaction system, 2-nitrophenyl hydrazine hydrochloride concentration is 1mg/mL, EDC HCl 2mg/mL, the response time is 2h.
Described HPLC-DAD method is preferred: use HPLC chromatogram instrument;Use reversed phase partition chromatography;With non-polar linkage phase For fixing phase, use polarity flowing phase, detection wavelength between 320-450nm, be further preferably positioned at 300~420nm it Between, further it is preferably placed between 390~400nm.
The instrument that the HPLC-DAD method stated further is preferably used is Shimadzu LC 20AT chromatograph of liquid, this color Spectrometer is formulated with online vacuum degassing machine, binary gradient pump, automatic sampler, column oven, DAD detector and LC-solution Chromatographic work station;Chromatographic column uses 250mm × 4.6mm, the Shimadzu Inertsil ODS-3 of 5 μm;Sample size: 20 μ L;Flowing phase Flow velocity: 1.0mL/min;Eluent gradient: A phase is acetonitrile, B phase is 0.1% phosphoric acid, 0min 28%A phase, 10min 40%A Phase, 14min 40%A phase, 20min 55%A phase;Column temperature: 40 DEG C;Detection wavelength: 392nm.
Method of the present invention can be used for the qualitative and quantitative detection of several samples small molecular halogenated carboxylic acid, preferably exists Measure the application in medicine small molecular halogenated carboxylic acid.
Derivatization HPLC-DAD method measures the method for medicine small molecular halogenated carboxylic acid, comprises the steps of
(1) under room temperature, under the activation of the hydrochlorate of carbodiimide class coupling agent, 2-nitrophenyl hydrazine hydrochloride is used Medicine to be measured performs the derivatization reaction 1~3h, and reactant liquor measures as sample feeding;Described carbodiimide class coupling agent choosing From dicyclohexylcarbodiimide, N, N'-DIC, in 1-ethyl-(3-dimethylaminopropyl) carbodiimide One, preferably 1-ethyl-(3-dimethylaminopropyl) carbodiimide;
(2) reactant liquor after terminating using derivative reaction in step (1), as sample introduction sample, utilizes HPLC-DAD method to exist 320-450nm measures the derivatization product of wherein halogenated carboxylic acid, thus realize the qualitative of medicine small molecular halogenated carboxylic acid or Detection by quantitative.
Wherein, wherein, described little molecule halogenated carboxylic acid preferably is selected from the carboxylic acid of C1~C6 of halogen substiuted, further preferably The carboxylic acid of C1~C4 of halogen substiuted, further preferably monoxone, bromoacetic acid, dichloroacetic acid, 2-chloropropionic acid, 3-chloropropionic acid or Any one in 2 bromopropionic acid.
Under the preferred room temperature of condition of derivative reaction, with acetonitrile-water that acetonitrile volumetric concentration is 10%~90% for reaction System, 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride concentration is 1~4mg/mL, 2-nitrophenyl hydrazine hydrochloride Concentration is 0.2~3mg/mL, and the response time is 1~3h;The condition of described derivative reaction further preferably with acetonitrile-water= 70:30 (V:V) is reaction system, 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride 2mg/mL, 2-Nitrobenzol Hydrazine hydrochloride concentration is 1mg/mL, and the response time is 2h.
HPLC-DAD method described in step (2) preferably employs HPLC chromatogram instrument;Use reversed phase partition chromatography;With non-pole Property Bonded Phase be fixing phase, use polarity flowing phase, detection wavelength, between 320-450nm, is preferably placed at 330~420nm Between, further preferably between 390~400nm;The instrument that described HPLC-DAD method is preferably used is Shimadzu LC 20AT chromatograph of liquid, this chromatograph is formulated with online vacuum degassing machine, binary gradient pump, automatic sampler, column oven, DAD Detector and LC-solution chromatographic work station;Chromatographic column uses 250mm × 4.6mm, the Shimadzu Inertsil ODS-3 of 5 μm; Sample size: 20 μ L;Flow rate of mobile phase: 1.0mL/min;Eluent gradient: A phase is acetonitrile, B phase is 0.1% phosphoric acid, 0min 28%A phase, 10min 40%A phase, 14min 40%A phase, 20min 55%A phase;Column temperature: 40 DEG C;Detection wavelength: 392nm.
What room temperature of the present invention referred to routine analyzes the temperature that carries out of experiment, usually between 10~30 DEG C.
Beneficial effect:
Present invention carboxylic acid based on Nitrobenzol hydrazine derivatization reagent derivatization product is due to nitro electron-withdrawing group on phenyl ring The existence of group, there is obvious redshift effect in ultraviolet absorption band.And most drug and impurity thereof are inhaled near visible district ultraviolet Receive the most weak, establish a kind of method that simple, general pre-column derivatization HPLC-DAD measures little molecule halogenated carboxylic acid.Methodology The result display medicine of checking common are machine acid and analysis all will not be interfered by other impurity, show that the method is exclusive Property is good.Additionally, the detection of method is limited to 0.02-0.05 μ g/mL, being quantitatively limited to 0.05-0.12 μ g/mL, linear relationship is good (r>0.999);1.98% and 4.39% in a few days it is respectively smaller than with day to day precision;Average recovery rate is between 82.4-105.6% (RSD < 4.30%), without obvious matrix interference;And derivatization product is good at 5h internal stability.
For the dechlorination reaction occurred during derivatization and chlorination, creatively find, by pyridine from derivatization The generation of dechlorination reaction and chlorination can be avoided when the catalyst system and catalyzing of reaction is rejected.Find based on this, to derivatization body System is optimized, and not only can ensure that halogenated carboxylic acid is by complete derivatization, moreover it is possible to be prevented effectively from the degraded of product.
Accompanying drawing explanation
Fig. 1: respectively with 2-nitrophenyl hydrazine (A), 3-nitrophenyl hydrazine (B), 4-nitrophenyl hydrazine (C), 2,4 dinitrophenyl hydrazine (D) The uv absorption spectra of product is generated as derivatization reagent and chloroacetate reaction.
Fig. 2: when trace dichloroacetic acid in chloromycetin (15mg/mL) (2.5 μ g/mL) being performed the derivatization with 2-nitrophenyl hydrazine The chromatogram (a-e represents different detection wavelength) obtained: a.224nm, b.275nm, c.337nm, d.356nm, e.392nm. (Imp 1-5 represents other endogenous impurity contained in chloromycetin crude drug)
Fig. 3: blank solution (a), formic acid (b), acetic acid (c), trifluoroacetic acid (d), methanesulfonic acid (e), benzene first under the same terms Acid (f), benzenesulfonic acid (g), p-methyl benzenesulfonic acid (h) and the chromatogram of 6 kinds little molecule halogenated carboxylic acid (i) derivatization products: (1) Monoxone derivant;(2) bromoacetic acid derivative;(3) 3-chloropropionic acid derivant;(4) 2-chloropropionic acid derivant;(5) 2 bromopropionic acid Derivant;(6) dichloroacetic acid derivant;(7) trifluoroacetic acid derivant;(8) benzoic acid derivative.The concentration of organic acid is 1 μ g/mL.Fig. 4: the reaction condition impact on halogenated carboxylic acid derivatization: (A) pyridine impact on halogenated carboxylic acid derivant stability; (B) the organic facies ratio impact on derivatization efficiency in system;(C) the 2-nitrophenyl hydrazine concentration impact on derivatization efficiency;(D) The response time impact on derivatization efficiency.B, C, D are all the results investigated under conditions of non-pyridine participates in.Determinand dense Degree is 1 μ g/mL.
Fig. 5: for verifying that pyridine is to the typical color spectrogram of derivatization stability influence and mass spectrum: (A) at pyridine and Individually dichloroacetic acid (a) and monoxone (b) are performed the derivatization in the presence of EDC HCl;(B) exist at pyridine and EDC HCl The most individually bromoacetic acid (d) and monoxone (b) are performed the derivatization;(C) individually to 2-bromine third in the presence of pyridine and EDC HCl Acid (f) and 2-chloropropionic acid (g) perform the derivatization.C, e, h represent respectively under the conditions of not having pyridine to participate in individually to dichloroacetic acid, Bromoacetic acid and 2 bromopropionic acid perform the derivatization.Testing concentration is 5 μ g/mL.
Detailed description of the invention
1.1. instrument
Shimadzu LC 20AT chromatograph of liquid (is contained in line vacuum degasser, binary gradient pump, automatic sampler, post Incubator, DAD detector and LC-solution chromatographic work station);Aglient 6520LC-TOF Liquid Chromatography-Tandem Mass Spectrometry instrument (it is contained in line vacuum degasser, high pressure binary gradient pump, automatic sampler, column oven, DAD detector, electron spray (ESI) interface With Agilent Mass Hunter Acquisition Software Ver.A.01.00 work station);METTLER TOLEDO AB135-S analytical balance (prunus mume (sieb.) sieb.et zucc. Teller swedish company);Sartorious BS110 analytical balance (the limited public affairs of Beijing Sai Duolisi Department).
1.2. reagent
Monoxone (98%), bromoacetic acid (98%), dichloroacetic acid (98%), 2-chloropropionic acid (97%), 2 bromopropionic acid (98%), 3-chloropropionic acid (98%), 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride (97%), 2-Nitrobenzol Hydrazine hydrochloride (97%), 3-nitrophenyl hydrazine hydrochloride (98%), 4-nitrophenyl hydrazine hydrochloride (98%) and 2,4 dinitrophenyl hydrazine (99.0%), tadanafil (97%), chloromycetin (95%), vitamin B6(98%), ibuprofen (98%), 5-(piperazine-1- Base) benzofuran-2-carboxamides (vilazodone intermediate, 99.2%), 6-hydroxyl-3,4-dihydro-2-quinolinone (Xi Luota Azoles, 99.5%), metalaxyl (97%), Chloramphenicol Eye Drop (8mL:20mg).
Purified water, acetonitrile (TEDIA, chromatographically pure), phosphoric acid (analytical pure), formic acid (analytical pure).
1.3. the preparation of solution
Each halogenated carboxylic acid storing solution (hereinafter referred to as HCA): take appropriate HCA, accurately weighed, it is placed in 10mL measuring bottle, uses 70% dilution in acetonitrile, to graduation mark, shakes up.Under each storing solution room temperature, 8h internal stability is good.
2-nitrophenyl hydrazine hydrochloride, 3-nitrophenyl hydrazine hydrochloride, 4-nitrophenyl hydrazine hydrochloride and 2,4 dinitrophenyl hydrazine examination Liquid (hereinafter referred to as 2-NPH HCl, 3-NPH HCl, 4-NPH HCl and DNPH): take each reagent about 100mg, accurately weighed, It is placed in 10mL measuring bottle, by 80% dilution in acetonitrile to scale, shakes up.Need Fresh.
1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride solution (hereinafter referred to as EDC HCl): take 1-second Base-(3-dimethylaminopropyl) carbodiimide hydrochloride 200mg, accurately weighed, it is placed in 10mL measuring bottle, dilute with 60% acetonitrile Release to scale, shake up.Need Fresh.
1.4. derivatization experiment condition
Accurately weighed appropriate medicine, or precision pipettes 100 μ L halogenated carboxylic acid reference substance test solutions, is placed in 5mL measuring bottle, respectively Add 500 μ L derivatization reagents and 500 μ L EDC HCl solution, add 70% dilution in acetonitrile to scale, vortex 10s, shake up.Keep away Photoreaction 2h, shakes up, and takes 20 μ L direct injected after filtration.
Embodiment 1
With monoxone as representative, with the 4 of same concentrations kinds of Nitrobenzol hydrazine derivatization reagents, it is performed the derivatization.Derivative Change experiment condition and see 1.4.Under identical chromatographic condition, scan each derivatization product, the spectrogram of record product and color with DAD Spectrogram, evaluates the quality of derivatization reagent with the maximum absorption wavelength of product and absorption intensity.
Fig. 1 shows, in addition to 3-nitrophenyl hydrazine, and the product uv absorption that other three kinds of derivatization reagents generate with monoxone Band all presents certain redshift effect, maximum absorption wavelength be respectively 392nm (2-nitrophenyl hydrazine) 356nm (4-nitrophenyl hydrazine) and 337nm (2,4 dinitrophenyl hydrazine).This experiment is ideally measured near visible district (400nm) place, can make Ambient interferences is preferably minimized, summarized chromatogram separation condition, improves method specificity[40,41].From fig. 1, 2-nitrophenyl hydrazine produces The redshift effect of thing is the most obvious, and other halogenated carboxylic acid derivants also show similar absorption characteristic.Therefore 2-nitrophenyl hydrazine is For properly;And from the point of view of the uv absorption intensity of each product, the absorption intensity of 2-nitrophenyl hydrazine product is higher than other three kinds.Therefore And, the present invention selects 2-nitrophenyl hydrazine to carry out follow-up study.
In actual test sample, due to the existence of high amount of drug substrate, shadow for the halogenated carboxylic acid derivatization product of trace Ringing relatively big, if promoting the use of, each medicine will be set up a chromatographic condition and go to separate medicine and impurity, and interference is many, sensitivity Low (baseline noise is big).And when using 2-nitrophenyl hydrazine as derivatization reagent, owing to most drug and impurity thereof closely may be used Jian Guang district (400nm) uv absorption is the most weak, so being measured being greatly improved the specificity of method at this wavelength, simplifies Chromatographic separation condition.Such as, when with 2-nitrophenyl hydrazine, the dichloroacetic acid in chloromycetin being performed the derivatization, and DAD record is used When difference detects the chromatogram under wavelength, (Fig. 2) finds, compared to other shorter wavelengths, the chromatogram under 392nm wavelength detecting The baseline more balanced and less Impurity Absorption peak can be provided, be conducive to improving baseline noise, reduce ambient interferences, improve The specificity of method and sensitivity[39,40].The fact that also have with other drug as the advantage that 2-nitrophenyl hydrazine is important Embody.
Embodiment 2
Prepared by need testing solution: accurately weighed appropriate medicine, is placed in 5mL measuring bottle, is separately added into 500 μ L derivatization reagents With 500 μ L EDC HCl solution, add 70% dilution in acetonitrile to scale, vortex 10s, shake up, lucifuge reaction 2h, shake up, obtain confession Test sample solution.20 μ L direct injected are taken after filtration.
Prepared by reference substance solution: precision pipettes 100 μ L variable concentrations halogenated carboxylic acid storing solutions, is placed in 5mL measuring bottle, respectively Add 500 μ L derivatization reagents and 500 μ L EDC HCl solution, add 70% dilution in acetonitrile to scale, vortex 10s, shake up, keep away Photoreaction 2h, shakes up, and obtains reference substance solution.20 μ L direct injected are taken after filtration.
Chromatographic condition: Shimadzu LC 20AT chromatograph of liquid (is contained in line vacuum degasser, binary gradient pump, automatically Injector, column oven, DAD detector and LC-solution chromatographic work station);Chromatographic column: Shimadzu Inertsil ODS-3 (250mm×4.6mm,5μm);Flowing phase: acetonitrile (A phase)-0.1% phosphoric acid (B phase), gradient elution is shown in Table 1, flow velocity: 1.0mL/ min;Sample size: 20 μ L;Column temperature: 40 DEG C;Detection wavelength: 392nm.
Table 1. gradient elution program
The bent method for drafting of mark: precision pipettes each reference substance storing solution and is placed in right amount in same 5mL measuring bottle respectively, adds 70% Dilution in acetonitrile, to scale, makes hybrid standard strain row strength solution.Perform the derivatization by method under 1.4. item, take 20 μ L and inject Chromatograph of liquid, measures the peak area of each derivatization product.With halogenated carboxylic acid concentration C (μ g/mL) as abscissa, derivatization product Peak area (A) is vertical coordinate, uses method of least square to carry out linear regression analysis, calculates equation of linear regression and correlation coefficient.
Quantitative approach: use external standard method to carry out quantitatively.
Embodiment 3
According to the method for embodiment 2, to monoxone, bromoacetic acid, 3-chloropropionic acid, 2-chloropropionic acid, 2 bromopropionic acid, dichloroacetic acid Investigate.From the i of Fig. 3, under above-mentioned chromatographic condition, 6 kinds of halogenated carboxylic acid derivatization products and derivatization reagent, urge Between agent, separating degree is preferable.In view of organic acid (formic acid, acetic acid, trifluoroacetic acid, methanesulfonic acid, benzene conventional in pharmaceutical synthesis Formic acid, benzenesulfonic acid and p-methyl benzenesulfonic acid) may react with 2-nitrophenyl hydrazine, so this experiment is the most right These seven kinds of organic acid are investigated, and study the mensuration of its material generated with 2-nitrophenyl hydrazine whether jamming target thing.Result is such as Fig. 3, the product after organic acid derivatization conventional in these seven kinds of pharmaceutical synthesis does not interferes with at the peak of determinand, and the party is described The specificity of method is good.
Embodiment 4
Research shows that carboxylic acid and amido reaction need through 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride The activation of (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride, EDC HCl) Can carry out, and activation process is frequently added pyridine as catalyst[41].Therefore, this experiment initially selects EDC HCl and pyrrole Pyridine accelerates hydrazides synthesis as catalyst system and catalyzing, and is successfully realized chloroacetic derivatization;But, when this condition is extended During to other detection objects, derivatization product occurs in that abnormal instability.
Precision pipettes 100 μ L halogenated carboxylic acid reference substance test solution (50 μ g/mL), is placed in 5mL measuring bottle, adds 500 μ L and derives Change reagent (10mg/mL), 500 μ L EDC HCl solution (20mg/mL) and 20 μ L pyridines, add 70% dilution in acetonitrile to scale, whirlpool Rotation 10s, shakes up.Lucifuge reaction 2h, shakes up, takes 20 μ L direct injected after filtration.
The A of Fig. 4 shows, when performing the derivatization 6 kinds of halogenated carboxylic acids simultaneously, along with the increase in response time, two chloroethenes The derivative peak response of acid, bromoacetic acid and 2 bromopropionic acid presents decline trend, correspondingly, and monoxone and the derivant of 2-chloropropionic acid Peak response continues to increase.In order to illustrate this phenomenon, we have individually carried out derivatization to each halogenated carboxylic acid, find to add simultaneously When adding EDC HCl and pyridine catalytic reaction, dichloroacetic acid derivant easily quick dealuminated USY cataluyst generates monoxone derivant;And Bromoacetic acid and 2 bromopropionic acid derivant easy debrominate generation chlorination form monoxone and 2-chloropropionic acid derivant.This phenomenon can Proved further from chromatographic retention and the mass spectral results of Fig. 5.By adjusting reaction temperature, system pH and change The type of nitrophenyl hydrazine all can not effectively solve the problems referred to above, and this hampers the popularization and application of the method significantly.
Embodiment 5
Owing to lacking the catalysis of pyridine, therefore when using the activator EDC HCl of high concentration (2mg/mL), in order to really Protect derivative reaction and avoid product degradation the most simultaneously, need the use of the ratio of organic facies, derivatization reagent in system Amount and response time are investigated.With the peak area of derivatization product that generates as index, single factor exploration variable concentrations 2-nitrophenyl hydrazine hydrochloride (0.2,0.5,0.8,1.0,1.25mg/mL), the ratio (10%, 30%, 50%, 70% of organic facies With 90%) and the response time (1,2,3,5,7h) impact on derivative reaction efficiency.Concrete outcome is shown in the B-D of Fig. 4.
Embodiment 6 Method validation and application
6.1. specificity
7 kinds of organic acid (formic acid, acetic acid, trifluoroacetic acid, first sulphur conventional in pharmaceutical synthesis has mainly been investigated in specificity test Acid, benzoic acid, benzenesulfonic acid and p-methyl benzenesulfonic acid) material interference to target derivant that generates with 2-nitrophenyl hydrazine.Result is such as Fig. 3, the product after these seven kinds of carboxylic acid derivatizations does not interferes with at the peak of determinand, illustrates that the specificity of the method is good.
6.2. linearity and range
Precision pipettes each reference substance storing solution and is placed in right amount in same 5mL measuring bottle respectively, adds 70% dilution in acetonitrile to carving Degree, makes hybrid standard strain row strength solution.Perform the derivatization by method under 1.4. item, take 20 μ L and inject chromatograph of liquid, Measure the peak area of each derivatization product.With halogenated carboxylic acid concentration C (μ g/mL) as abscissa, derivatization peak areas (A) is Vertical coordinate, uses method of least square to carry out linear regression analysis, calculates equation of linear regression and correlation coefficient.Result shows, chlorine Acetic acid and the 2-chloropropionic acid range of linearity are 0.05~0.5 μ g/mL, and bromoacetic acid, dichloroacetic acid and the 3-chloropropionic acid range of linearity are 0.08~0.8 μ g/mL, the 2 bromopropionic acid range of linearity is 0.12~1.2 μ g/mL.And each determinand linear relationship good (r > 0.999).The results are shown in Table 2.
6.3. detection limit and quantitative limit
Detection limit with signal to noise ratio 3:1 as method, the quantitative limit with signal to noise ratio 10:1 as method.Result shows, 6 kinds of halos The detection of carboxylic acid limits between 0.02~0.05 μ g/mL, and quantitative limit is between 0.05~1.2 μ g/mL.Specifically it is shown in Table 2.
6.4. precision test (withinday precision and day to day precision)
Prepare 100% limit level (0.2~0.6 μ g/mL) hybrid standard product solution by method under 6.2. item, take 100 μ L Above-mentioned solution, is placed in 5ml measuring bottle, after under 1.4. item, method addition derivatization reagent and activator carry out pre-treatment, and day Interior precision repeats sample introduction 6 times, and day to day precision repeats sample introduction 6 times, with derivatization product calculated by peak area every day for three days on end RSD value.As shown in Table 2, the withinday precision of the method and day to day precision are good, and RSD is respectively smaller than 1.98% and 4.39%.
6.5. derivant stability
Prepare 100% limit level (0.2~0.6 μ g/mL) hybrid standard product solution by method under 6.2. item, take 100 μ L Above-mentioned solution, is placed in 5ml measuring bottle, after method performs the derivatization under 1.4. item, sets to 0 respectively at ambient temperatare, 1,2,3, It is measured during 5h, investigates the stability of derivant with the change of determinand peak area.As shown in Table 2, derivatization product room temperature During placement, in 0~5h, the RSD of peak area is less than 4.62%, i.e. has good stability.
Table 2 methodology result of the test
The concentration (μ g/mL) of x-determinand, y-peak area, the correlation coefficient of r regression equation.
6.6. average recovery
In order to evaluate the accuracy of the method, we calculate the average recovery of each halogenated carboxylic acid respectively.The medicine related to Thing background includes tadanafil (5mg/mL), chloromycetin (15mg/mL), vitamin B6(8mg/mL), ibuprofen (8mg/mL), first Frost spirit (10mg/mL), vilazodone intermediate (1mg/mL), cilostazol intermediate (8mg/mL) and Chloramphenicol Eye Drop (1mg/mL)。
Response rate contrast solution: prepare 100% limit level (0.2~0.6 μ g/mL) single standard by 6.2 lower methods Product solution, is not added with medicine background, performs the derivatization by method under 1.4. item, takes 20 μ L sample introductions after filtration.Each concentration level 6 Part.
Response rate sample solution: precision weighs appropriate each medicine background, is placed in 5mL measuring bottle, is separately added into 100 μ L 100% limit horizontal single standard product solution, derivatization after the same method, take 20 μ L sample introductions after filtration.Each concentration water Flat 6 parts.
Average recovery=(sample peak area background peak area)/reference substance peak area × 100%.
And calculate meansigma methods and the RSD of each concentration level average recovery.
As shown in Table 3, the average recovery of each halogenated carboxylic acid is all between 82.4~105.6%, and RSD is respectively less than 4.30%.
Embodiment 7
Maximum taking dose according to medicine and each impurity TTC value, prepare the need testing solution of finite concentration medicine.Press 1.4. item method performs the derivatization, and takes 20 μ L sample introductions according to embodiment 2 method after filtration, records the peak area of derivatization product, Calculate determinand content (μ g/g) in medicine.
Result shows, except vitamin B6, outside vilazodone intermediate and cilostazol intermediate, remaining 5 kinds of medicine is equal Corresponding halogenated carboxylic acid can be detected.Wherein, the monoxone in tadanafil sample, the 2-chloropropionic acid in ibuprofen sample and 2 bromopropionic acid content in metalaxyl sample is all not less than quantitative limit level (< 12 μ g/g).But, chloromycetin crude drug and chlorine are mould Dichloroacetic acid content in element eye drop respectively reaches 167 μ g/g and 454 μ g/g, and be all above standard limit.
Table 3 the method application result in 8 kinds of medicine samples
a: detection limit (μ g/g) is expressed as [detection limit (μ g/mL) of determinand]/[concentration (mg/mL) of medicine].
b: quantitative limit (μ g/g) is expressed as [quantitative limit (μ g/mL) of determinand]/[concentration (mg/mL) of medicine].
ND: be not detected by.
List of references
[1]J.E.Andrews,H.P.Nichols,J.E.Schmid,L.M.Mole,E.S.Hunter III, G.R.Klinefelter,Developmental toxicity of mixtures:the water disinfection by- products dichloro-,dibromo-and bromochloro acetic acid in rat embryo culture, Reprod.Toxicol.19(2004)111-116.
[2]S.D.Richardson,M.J.Plewa,E.D.Wagner,R.Schoeny,D.M.DeMarini, Occurrence,genotoxicity,and carcinogenicity of regulated and emerging disinfection by-products in drinking water:a review and roadmap for research, Mutat.Res.636(2007)178-242.
[3]US Environmental Protection Agency,Stage 2 Disinfectants and disinfection byproducts rule, EPA-HQ-OW-2002-0043,Washington,DC,2006.
[4]World Health Organization,Guidelines for Drinking-Water Quality (2006)http://www.who.int/watersanitation health/dwq/gdwq0506.pdf.
[5]Y.S.Hwang,H.A.Navvab-Gojrati,M.S.Mulla,Overcrowding Factors of Mosquito Larvae.11.Biological Activity of 2-Halooctadecanoic Acids and Alkyl 2-Halooctadecanoates against Mosquito Larvae,J.Agric.Food Chem.26(1978)1294.
[6]Moser,Hans,Phenylaminoacetamides for regulating plantgrowth,US 4008066,1997.
[7]C.Loncaric,W.D.Wulff,An efficient synthesis of(-)-chloramphenicol via asymmetric catalytic aziridination:a comparison of catalysts prepared from triphenylborate and various linear and vaulted biaryls,Org.Lett.3(2001) 3675-3678.
[8]X.T.Li,J.Sui,X.M.Yang,Environment friendly synthesis of 1- chloroethyl 4-isobutylphenyl ketone,CN 200510200040,2005.
[9]P.B.Deshpande,B.B.Boda,S.S.Surti,P.P.Shah,Process for preparation of Tadalafil and its intermediate,US 7223863,2007.
[10]A.Bathe,S.Emmert,B.Helfert,H.Boettcher,Preparation of5-(1- Piperazinyl)-benzofuran-2-carboxamide,WO2001040219,2001.
[11]B.S.Lee,I.K.Park,S.F.Shin,Preparation of 6-hydroxy-2-oxo-1,2,3,4- tetrahydroquinoline,JP:2000229944,2000.
[12]S.A.Harris,K.Folkers,Synthesis of vitamin B6,J.Am.Chem.Soc.61 (1939)1245-1247.
[13]Z.S.Zhang,Q.B.Zhang,J.Wang,X.L.Shi,J.J.Zhang,H.F.Song,Synthesis and drug release in vitro of porphyran carrying 5-Fluorouracil, Carbohydr.Polym.79(2010)628-632.
[14]M.H.Nie,Y.Yang,Z.J.Zhang,C.X.Yan,X.N.Wang,H.J.Li,W.B.Dong, Degradation of chloramphenicol by thermally activated persulfate in aqueous solution,Chem.Eng.J.246(2014)373-382.
[15]Committee for Medicinal Products for Human Use(CHMP)Guidelines on the limits of genotoxic impurities(CPMP/SWP/5199/02)[S].London:European Medicines Agency Evaluation of Medicines for Human Use(EMEA),2006.
[16]L.Müller,R.J.Mauthe,C.M.Riley,M.M.Andio et al.A rationale for determining,testing,and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity,Regul.Toxicol.Pharm.44(2006)198–211.
[17]International Conference on Harmonisation(ICH),Assessment and Control of DNA Reactive(Mutagenic)Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk,Guideline M7,2013,Geneva,Switzerland.
[18]USEPA,Method 552:Determination of Haloacetic Acids in Drinking Water by Liquid–Liquid Extraction,Derivatization and Gas Chromatography with Electron Capture Detector,Environmental Monitoring and System Laboratory, Cincinnati,OH,1990.
[19]USEPA,Method 552.2:Dalapon in Drinking Water by Ion Exchange Liquid Solid Extraction,Derivatization and Gas Chromatography with Electron Capture Detector,Environmental Monitoring and System Laboratory,Cincinnati, OH,1995.
[20]USEPA,Method 552.1:Determination of Haloacetic Acids and Dalapon in Drinking Water by Ion Exchange Liquid Solid Extraction,Derivatization and Gas Chromatography with Electron Capture Detection,Environmental Monitoring and System Laboratory,Cincinnati,OH,1992.
[21]USEPA,Method 552.3:Determination of Haloacetic Acids and Dalapon in Drinking Water by Liquid–liquid Microextraction,Derivatization and Gas Chromatography with Electron Capture Detection,Environmental Monitoring and System Laboratory,Cincinnati,OH,2003.
[22]L.M.Nair,R.Saari-Nordhaus,J.M.Anderson,Determination of haloacetic acids by ion chromatography,J.Chromatogr.A.671(1994)309-313.
[23]M.C.Bruzzoniti,R.S.De Carlo,K.Horvath,D.Perrachon et al.High performance ion chromatography of haloacetic acids on macrocyclic cryptand anion exchanger,J.Chromatogr.A.1187(2008)188-196.
[24]K.Alhooshani,C.Basheer,J.Kaur.A.Gjelstad,K.E.Rasmussen, S.Pedersen-Bjergaard,H.K.Lee,Electromembrane extraction and HPLC analysis of haloacetic acids and aromatic acetic acids in wastewater,Talanta,86(2011)109- 113.
[25]H.Nsubugaa,C.Basheer,Determination of haloacetic acids in swimming pool waters by membrane-protected micro-solid phase extraction, J.Chromatogr.A.1315(2013)47-52.
[26]A.D.Delinsky,D.C.Delinsky,S.Muralidhara,J.W.Fisher,J.V.Bruckner, M.G.Bartlett,Analysis of dichloroacetic acid in rat blood and tissues by hydrophilic interaction liquid chromatography with tandem mass spectrometry.Rapid Commun.Mass Spectrom.19(2005)1075-1083.
[27]M.Saraji,A.A.H.Bidgoli,Single-drop microextraction with in- microvial derivatization for the determination of haloacetic acids in water sample by gas chromatography–mass spectrometry,J.Chromatogr.A.1216(2009)1059- 1066.
[28]M.J.Cardador,M.Gallego,Haloacetic acids content of fruit juices and soft drinks,Food Chem.173(2015)685-693.
[29]L.P.Meng,S.M.Wu,F.J.Ma,A.Jia,J.Y.Hu,Trace determination of nine haloacetic acids in drinking water by liquid chromatography–electrospray tandem mass spectrometry,J.Chromatogr.A.1217(2010)4873-4876.
[30]C.Y.Chen,S.N.Chang,G.S.Wang,Determination of ten haloacetic acids in drinking water using high-performance and ultra-performance liquid chromatography–tandem mass spectrometry,J.Chromatogr.Sci.47(2009)67-74.
[31]R.Loos,D.Barceló,Determination of haloacetic acids in aqueous environments by solid-phase extraction followed by ion-pair liquid chromatography–electrospray ionization mass spectrometric detection, J.Chromatogr.A.938(2001)45-55.
[32]M.C.Prieto-Blanco,M.F.Alpendurada,P.López-Mahía,S.Muniategui- Lorenzoa,D.Prada-Rodríguez,S.Machadob,C.Gon alves,Improving methodological aspects of the analysis of five regulated haloacetic acids in water samples by solid-phase extraction,ion-pair liquid chromatography and electrospray tandem mass spectrometry,Talanta,94(2012)90-98.
[33]D.Q.Liu,M.J.Sun,A.S.Kord,Recent advances in trace analysis of pharmaceutical genotoxic impurities,J.Pharm.Biomed.Anal.51(2010)999-1014.
[34]T.Y.Shi,T.Tang,K.Qian,F.Wang,J.Q.Li,Y.S.Cao,High-performance liquid chromatographic method for determination of amino acids by precolumn derivatization with4-chloro-3,5-dinitrobenzotrifluoride,Anal.Chim.Acta.654 (2009)154-161.
[35]P.S.Simone Jr.,P.L.Ranaivo,G.Geme,M.A.Brown,G.L.Emmert,On-line monitoring of nine haloacetic acid species at theμg L-1 level using post- column reaction-ion chromatography with nicotinamide fluorescence, Anal.Chim.Acta.654(2009)133-140.
[36]A.Ghassempour,S.Chalavi,A.Abdollahpour,S.A.Mirkhani,Determination of mono-and dichloroacetic acids in betaine media by liquid chromatography, Talanta,68(2006)1396-1400.
[37]V.Neua,C.Bielowb,K.Reinertb,C.G.Huber,Ultrahigh-performance liquid chromatography-ultraviolet absorbance detection-high-resolution-mass spectrometry combined with automated data processing for studying the kinetics of oxidative thermal degradation of thyroxine in the solid state, J.Chromatogr.A.1371(2014)196-203.
[38]G.O.Noonan,T.H.Begley,G.W.Diachenko,Rapid quantitative and qualitative confirmatory method for the determination of monofluoroacetic acid in foods by liquid chromatography-mass spectrometry,J.Chromatogr.A.1139 (2007)271–278.
[39]H.Miwa,M.Yamamoto,T.Nishida,K.Nunoi,M.Kikuchi,High-performance liquid chromatographic analysis of serum long-chain fatty acids by direct derivatization method,J.Chromatogr.B,Biomed.Appl.416(1987)237-245.
[40]H.Miwa,High-performance liquid chromatographic determination of free fatty acids and esterified fatty acids in biological materials as their 2-nitrophenylhydrazides,Anal.Chim.Acta.465(2002)237-255.
[41]R.Peters,J.Hellenbrand,Y.Mengerink,Sj.Van der Wal,On-line determination of carboxylic acids,aldehydes and ketones by high-performance liquid chromatography-diode array detection-atmospheric pressure chemical ionisation mass spectrometry after derivatization with 2- nitrophenylhydrazine,J.Chromatogr.A.1031(2004)35-50.
[42]Y.Chikako,O.Yukiko,Determination of biotin following derivatization with2-nitrophenylhydrazine by high-performance liquid chromatography with on-line UV detection and electrospray-ionization mass spectrometry,J.Chromatogr.A.1142(2007)231-235.
[43]K.Michail,H.Juan,A.Maier,V.Matzi,J.Greilberger,R.Wintersteiger, Development and validation of a liquid chromatographic method for the determination of hydroxymethylfurfural and alpha-ketoglutaric acid in human plasma Anal.Chim.Acta.581(2007)287-297.
[44]J.Han,K.R.Lin,C.Sequeira,C.H.Borchers,An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry, Anal.Chim.Acta.854(2015)86-94.
[45]G.Ramazan,A.Nail,Quantification of 5-hydroxymethylfurfural in honey samples and acidic beverages using spectrophotometry coupled with ultrasonic-assisted cloud point extraction,J.Food.Compos.Anal.42(2015)141- 151.
[46] T.W.Graham Solomons, C.B.Fryhle, organic chemistry, the 8th edition, Beijing Interpharm Press, 2005.
[47]J.A.Zoltewicz,L.W.Deady,Quaternization of Heteroaromatic Compounds:Quantitative Aspects,Adv.Heterocyc.Chem.22(1978)71-121。

Claims (11)

1. the method that derivatization HPLC-DAD method measures little molecule halogenated carboxylic acid, it is characterised in that comprise the steps of
(1) at normal temperatures, use Nitrobenzol hydrazine derivatization reagent to little molecule halogenated carboxylic acid derivative reaction, generate at 320- 450nm has the relatively strong product absorbed;
(2) with derivative reaction product in step (1), HPLC-DAD method is utilized, based on reversed phase partition chromatography principle, at 320- 450nm measures the derivatization product of wherein halogenated carboxylic acid, thus realizes the qualitative or quantitative detection to little molecule halogenated carboxylic acid.
Method the most according to claim 1, it is characterised in that comprise the steps of
(1) at normal temperatures, with acetonitrile-water as reaction system, Nitrobenzol hydrazine derivatization reagent is used, with carbodiimide class coupling The hydrochlorate of agent is activator, generates little molecule halogenated carboxylic acid derivative reaction and has the relatively strong product absorbed at 330~420 nm Thing;
(2) with derivative reaction product in step (1), utilize HPLC-DAD method, based on reversed phase partition chromatography principle 330~ 420 nm measure the derivatization product of wherein halogenated carboxylic acid, thus realize the qualitative or quantitative detection to little molecule halogenated carboxylic acid.
Method the most according to claim 2, it is characterised in that described little molecule halogenated carboxylic acid is the C1 ~ C6 of halogen substiuted Carboxylic acid;Described carbon carbodiimide class coupling agent is selected from dicyclohexylcarbodiimide, N, N'-DIC, 1- Any one in ethyl-(3-dimethylaminopropyl) carbodiimide;Nitrobenzol hydrazine derivatization reagent is selected from 2-Nitrobenzol Any one in hydrazine hydrochloride, 3-nitrophenyl hydrazine hydrochloride, 4-nitrophenyl hydrazine hydrochloride and 2,4 dinitrophenyl hydrazine.
Method the most according to claim 3, it is characterised in that described little molecule halogenated carboxylic acid is selected from monoxone, bromine second Any one in acid, dichloroacetic acid, 2-chloropropionic acid, 3-chloropropionic acid or 2 bromopropionic acid;Described carbon carbodiimide class coupling agent For 1-ethyl-(3-dimethylaminopropyl) carbodiimide, described Nitrobenzol hydrazine derivatization reagent is 2-Nitrobenzol hydrazonium salt Hydrochlorate.
Method the most according to claim 4, it is characterised in that in acetonitrile-water reaction system the volumetric concentration of acetonitrile be 10% ~ 90%;1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride concentration is 1 ~ 4 mg/mL, 2-nitrophenyl hydrazine hydrochloride Concentration in derivative reaction system is 0.2~3 mg/mL;The derivative reaction time is 1 ~ 3h.
Method the most according to claim 1, it is characterised in that the HPLC-DAD method described in step (2) uses HPLC chromatogram Instrument;Use reversed phase partition chromatography;With non-polar linkage for fixing phase, using polarity flowing phase, detection wavelength is positioned at 320- Between 450nm, it is preferably placed between 330~420 nm, is further preferably positioned between 390 ~ 400nm.
7. the application in measuring medicine small molecular halogenated carboxylic acid of the method according to any one of claim 1 ~ 6.
8. the method that derivatization HPLC-DAD method measures medicine small molecular halogenated carboxylic acid, it is characterised in that comprise the steps of
(1) under room temperature, under the activation of the hydrochlorate of carbodiimide class coupling agent, Nitrobenzol hydrazine derivatization reagent is used Medicine to be measured is performed the derivatization reaction, and reactant liquor measures as sample feeding;
(2) reactant liquor after terminating using derivative reaction in step (1), as sample introduction sample, utilizes HPLC-DAD method at 320- 450nm measures the derivatization product of wherein halogenated carboxylic acid, thus realize medicine small molecular halogenated carboxylic acid qualitative or quantitative Detection.
Method the most according to claim 8, it is characterised in that described little molecule halogenated carboxylic acid selected from halogen substiuted C1 ~ Any one in the carboxylic acid of C6, preferably monoxone, bromoacetic acid, dichloroacetic acid, 2-chloropropionic acid, 3-chloropropionic acid or 2 bromopropionic acid; Described carbodiimide class coupling agent salt is selected from dicyclohexylcarbodiimide, N, N'-DIC, 1-ethyl-(3- Dimethylaminopropyl) one in carbodiimide, preferably 1-ethyl-(3-dimethylaminopropyl) carbodiimide;Described Nitrobenzol hydrazine derivatization reagent selected from 2-nitrophenyl hydrazine hydrochloride, 3-nitrophenyl hydrazine hydrochloride, 4-nitrophenyl hydrazine hydrochloride With any one in 2,4 dinitrophenyl hydrazine, preferably 2-nitrophenyl hydrazine hydrochloride.
Method the most according to claim 8, it is characterised in that the condition of derivative reaction is under room temperature, with acetonitrile volume Concentration be the acetonitrile-water of 10% ~ 90% be reaction system, 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride concentration Being 1 ~ 4 mg/mL, 2-nitrophenyl hydrazine hydrochloride concentration is 0.2 ~ 3mg/mL, and the response time is 1 ~ 3h;Described derivative reaction Condition preferably with acetonitrile-water=70:30(V:V) as reaction system, 1-ethyl-(3-dimethylaminopropyl) carbodiimide salt Hydrochlorate 2 mg/mL, 2-nitrophenyl hydrazine hydrochloride concentration is 1mg/mL, and the response time is 2h.
11. methods according to claim 9, it is characterised in that the HPLC-DAD method described in step (2) uses HPLC color Spectrometer;Use reversed phase partition chromatography;With non-polar linkage for fixing phase, using polarity flowing phase, detection wavelength is positioned at Between 320-450nm, it is preferably placed between 330 ~ 420nm, is further preferably positioned between 390 ~ 400nm;Described HPLC- The instrument that DAD method is preferably used is Shimadzu LC 20AT chromatograph of liquid, this chromatograph be formulated with online vacuum degassing machine, Binary gradient pump, automatic sampler, column oven, DAD detector and LC-solution chromatographic work station;Chromatographic column uses 250 Mm × 4.6 mm, the Shimadzu Inertsil ODS-3 of 5 μm;Sample size: 20 μ L;Flow rate of mobile phase: 1.0 mL/min;Flowing phase Gradient: A phase is acetonitrile, B phase is 0.1% phosphoric acid, 0min 28%A phase, 10min 40%A phase, 14min 40%A phase, 20min 55% A phase;Column temperature: 40 DEG C;Detection wavelength: 392 nm.
CN201510933250.5A 2015-12-15 2015-12-15 The method that derivatization HPLC DAD methods determine medicine small molecular halogenated carboxylic acid Active CN105758984B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510933250.5A CN105758984B (en) 2015-12-15 2015-12-15 The method that derivatization HPLC DAD methods determine medicine small molecular halogenated carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510933250.5A CN105758984B (en) 2015-12-15 2015-12-15 The method that derivatization HPLC DAD methods determine medicine small molecular halogenated carboxylic acid

Publications (2)

Publication Number Publication Date
CN105758984A true CN105758984A (en) 2016-07-13
CN105758984B CN105758984B (en) 2017-07-14

Family

ID=56341743

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510933250.5A Active CN105758984B (en) 2015-12-15 2015-12-15 The method that derivatization HPLC DAD methods determine medicine small molecular halogenated carboxylic acid

Country Status (1)

Country Link
CN (1) CN105758984B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107014944A (en) * 2017-03-26 2017-08-04 中国药科大学 The method that derivatization HPLC DAD methods determine acyl chlorides in medicine or its synthetic intermediate
CN107085068A (en) * 2017-06-28 2017-08-22 中国药科大学 The method that derivatization HPLC-DAD methods determine medicine small molecular fatty amine
CN109991358A (en) * 2019-04-09 2019-07-09 上海实朴检测技术服务有限公司 Measure chloroacetic method in soil
CN110632243A (en) * 2019-10-23 2019-12-31 中国日用化学研究院有限公司 Method for simultaneously determining contents of glycolic acid, monochloroacetic acid and dichloroacetic acid in alcohol ether carboxylate
CN113484445A (en) * 2021-08-03 2021-10-08 杭州微源检测技术有限公司 Method for detecting content of 5-chloropentanoic acid
CN113514582A (en) * 2021-07-09 2021-10-19 四川武胜春瑞医药化工有限公司 Impurity detection method for p-nitro-alpha-acetamido-beta-hydroxy propiophenone
CN113624872A (en) * 2021-08-03 2021-11-09 杭州微源检测技术有限公司 Method for detecting content of 2-bromobutyric acid in etiracetam
CN115266986A (en) * 2022-07-29 2022-11-01 江苏慧聚药业股份有限公司 Method for measuring EDCI residue in Toxolitinib

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010050254A1 (en) * 1998-01-09 2001-12-13 Christopher J. Welch Method for screening chromatographic adsorbents
EP1239280A2 (en) * 2001-02-26 2002-09-11 Pfizer Products Inc. ElogDoct:A tool for lipophilicity determination in drug discovery basic and neutral compounds
CN101292162A (en) * 2005-08-15 2008-10-22 斯克利普斯研究院 Methods to identify therapeutic agents
CN101680882A (en) * 2007-05-29 2010-03-24 药物诊断股份有限公司 Reagents and methods for the determination of pk/adme-tox characteristics of new chemical entities and of drug candidates
CN102317786A (en) * 2007-04-18 2012-01-11 特提斯生物科学公司 Diabetes correlativity biological marker and method of application thereof
CN104987379A (en) * 2015-07-08 2015-10-21 武汉市畜牧兽医科学研究所 Differential protein in serum at early pregnancy stage of cow and application of differential protein

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010050254A1 (en) * 1998-01-09 2001-12-13 Christopher J. Welch Method for screening chromatographic adsorbents
EP1239280A2 (en) * 2001-02-26 2002-09-11 Pfizer Products Inc. ElogDoct:A tool for lipophilicity determination in drug discovery basic and neutral compounds
CN101292162A (en) * 2005-08-15 2008-10-22 斯克利普斯研究院 Methods to identify therapeutic agents
CN102317786A (en) * 2007-04-18 2012-01-11 特提斯生物科学公司 Diabetes correlativity biological marker and method of application thereof
CN101680882A (en) * 2007-05-29 2010-03-24 药物诊断股份有限公司 Reagents and methods for the determination of pk/adme-tox characteristics of new chemical entities and of drug candidates
CN104987379A (en) * 2015-07-08 2015-10-21 武汉市畜牧兽医科学研究所 Differential protein in serum at early pregnancy stage of cow and application of differential protein

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107014944A (en) * 2017-03-26 2017-08-04 中国药科大学 The method that derivatization HPLC DAD methods determine acyl chlorides in medicine or its synthetic intermediate
CN107085068A (en) * 2017-06-28 2017-08-22 中国药科大学 The method that derivatization HPLC-DAD methods determine medicine small molecular fatty amine
CN109991358A (en) * 2019-04-09 2019-07-09 上海实朴检测技术服务有限公司 Measure chloroacetic method in soil
CN110632243A (en) * 2019-10-23 2019-12-31 中国日用化学研究院有限公司 Method for simultaneously determining contents of glycolic acid, monochloroacetic acid and dichloroacetic acid in alcohol ether carboxylate
CN110632243B (en) * 2019-10-23 2021-10-12 中国日用化学研究院有限公司 Method for simultaneously determining contents of glycolic acid, monochloroacetic acid and dichloroacetic acid in alcohol ether carboxylate
CN113514582A (en) * 2021-07-09 2021-10-19 四川武胜春瑞医药化工有限公司 Impurity detection method for p-nitro-alpha-acetamido-beta-hydroxy propiophenone
CN113514582B (en) * 2021-07-09 2022-07-12 四川武胜春瑞医药化工有限公司 Impurity detection method for p-nitro-alpha-acetamido-beta-hydroxy propiophenone
CN113484445A (en) * 2021-08-03 2021-10-08 杭州微源检测技术有限公司 Method for detecting content of 5-chloropentanoic acid
CN113624872A (en) * 2021-08-03 2021-11-09 杭州微源检测技术有限公司 Method for detecting content of 2-bromobutyric acid in etiracetam
CN115266986A (en) * 2022-07-29 2022-11-01 江苏慧聚药业股份有限公司 Method for measuring EDCI residue in Toxolitinib

Also Published As

Publication number Publication date
CN105758984B (en) 2017-07-14

Similar Documents

Publication Publication Date Title
CN105758984B (en) The method that derivatization HPLC DAD methods determine medicine small molecular halogenated carboxylic acid
Cervino et al. Use of isotope-labeled aflatoxins for LC-MS/MS stable isotope dilution analysis of foods
He et al. Simultaneous determination of food-related biogenic amines and precursor amino acids using in situ derivatization ultrasound-assisted dispersive liquid–liquid microextraction by ultra-high-performance liquid chromatography tandem mass spectrometry
Schenzel et al. Multi-residue screening method to quantify mycotoxins in aqueous environmental samples
Zhang et al. Determination of melamine and cyanuric acid in human urine by a liquid chromatography tandem mass spectrometry
Calbiani et al. Rapid assay for analyzing biogenic amines in cheese: matrix solid-phase dispersion followed by liquid chromatography− electrospray− tandem mass spectrometry
Chen et al. Effective monitoring of fluxapyroxad and its three biologically active metabolites in vegetables, fruits, and cereals by optimized QuEChERS treatment based on UPLC-MS/MS
Teasdale et al. Analytical control strategies for mutagenic impurities: current challenges and future opportunities?
Percy et al. Determination of Citrus aurantium protoalkaloids using HPLC with acidic potassium permanganate chemiluminescence detection
Myers et al. On-column nitrosation of amines observed in liquid chromatography impurity separations employing ammonium hydroxide and acetonitrile as mobile phase
Luo et al. Development of a stability–indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance
Nojiri et al. Fluorescence detection of biotin using post-column derivatization with OPA in high performance liquid chromatography
Gričar et al. Determination of azide impurity in sartans using reversed-phase HPLC with UV detection
Saini et al. Development and validation of a novel method for simultaneous quantification of enzalutamide, darolutamide and their active metabolites in mice dried blood spots using LC-MS/MS: Application to pharmacokinetic study in mice
Rao et al. Separation and determination of synthetic impurities of norfloxacin by reversed-phase high performance liquid chromatography
Wang et al. Absolute quantitation of N-nitrosamines by coulometric mass spectrometry without using standards
CN109900830A (en) Using the method and application of sulfonamides impurity in HPLC separation determination celecoxib
Dhiman et al. Determination of epacadostat, a novel IDO1 inhibitor in mouse plasma by LC–MS/MS and its application to a pharmacokinetic study in mice
Shah et al. Stability indicating LC-MS/MS method and validation of selexipag impurities and identification of its force degradation products
Dixit et al. Determination of tofacitinib in mice whole blood on dried blood spots using LC–ESI–MS/MS: application to pharmacokinetic study in mice
CN108828089A (en) The method that derivatization HPLC-UV/Vis method measures 4- nitrobenzaldehyde in chloramphenicol or its preparation
Hou et al. Determination of small halogenated carboxylic acid residues in drug substances by high performance liquid chromatography-diode array detection following derivatization with nitro-substituted phenylhydrazines
Draper et al. Electrolyte-induced ionization suppression and microcystin toxins: Ammonium formate suppresses sodium replacement ions and enhances protiated and ammoniated ions for improved specificity in quantitative LC-MS-MS
Zádori et al. Time-course of kynurenic acid concentration in mouse serum following the administration of a novel kynurenic acid analog
CN107941946A (en) A kind of detection method of Vonoprazan fumarate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant